Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Drreddys Laboratories

Drreddys Laboratories reported INR206.94B in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
ANI Pharmaceuticals ANIP:US USD 364.75M 20.49M
Bayer BAYN:GR EUR 39.62B 1.86B
Catalent CTLT:US USD 2.92B 220M
Corcept Therapeutics CORT:US USD 533.89M 34.64M
Drreddys Laboratories RDY:US INR 206.94B 12.45B
Endo International ENDP:US USD 1.93B 145.01M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Hikma Pharmaceutical HIK:LN USD 2B 145M
Horizon Pharma HZNP:US USD 3.6B 50M
Lonza Group LONN:SW CHF 5.72B 13M
Novartis NOVN:VX USD 32.11B 4.8B
Pacira PCRX:US USD 376.11M 122.22M
Phibro Animal Health PAHC:US USD 585.48M 3.79M
Prestige Brands PBH:US USD 391.74M 17.1M
Richter Gedeon RICHT:HB HUF 573.53B 2.24B
Supernus Pharmaceuticals SUPN:US USD 883.34M 149.19M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 11.5B 550M